30929

30929
Packer M, Anker SD, Butler J, et al. Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: The EMPEROR-Reduced trial. Eur Heart J 2021; 42(6):671–80. DOI: 10.1093/eurheartj/ehaa968. http://www.ncbi.nlm.nih.gov/pubmed/33459776
Einstellungen
30929
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 29.11.2023 | 10:39 Uhr